To further examine the role of monocytes and pDC for anti-tumor immunity, we repeated PBMC-CM toxicity, NK cell activation and degranulation assays, as well as T cell priming experiments but depleted CD14+ monocytes, pDC, or both, from the whole PBMC population. Here, CD14 is linked to neoplasm.